CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Qingdao Vland Biotech INC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Qingdao Vland Biotech INC
No. 596-1
Jiushui East Road, Laoshan District
Phone: +86 53288978071p:+86 53288978071 QINGDAO, SDG  266100  China Ticker: 603739603739
Business Summary
Qingdao Vland Biotech Inc is a China-based company principally engaged in the research, development, production, and sales of enzyme preparations, microecological preparations, and animal health products. The Company operates through two main segments. The Biological segment primarily includes enzyme preparations and microecological products. The Animal Health segment mainly covers veterinary chemical drugs, traditional Chinese veterinary medicines, and biological products. The Company provides technological support for biomanufacturing, clean and energy-saving solutions for traditional industries, and green solutions for food safety. The Company’s products and services are applied in agriculture, food, cleaning, health, environmental protection, and biocatalysis industries. The Company mainly operates its businesses in the domestic and overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board BingliangHuang 68
Chief Financial Officer PiyuanQiao 46
General Manager, Director GangChen 48
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 1,571 (As of 12/31/2023)
Outstanding Shares: 253,028,866 (As of 9/30/2025)
Shareholders: 22,267
Stock Exchange: SHA
Fax Number: +86 53288966609


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, January 8, 2026